News
Events
Research
Ways to help
About us
Contact Us
DONATE NOW
EVENTS
ANNUAL BALL
CONTACT US
SIGN UP TO NEWSLETTER
Feb 2017
Trish Foundation contributes to first-ever discovery
Jun 2017
Researchers funded by the Trish Foundation making great progress
Dec 2014
2015 Funding announced
Mar 2015
Investigating new treatment options
Oct 2015
Progress in MS Research Conference
Feb 2016
2016 Round of Funding
Sep 2016
Dr Gu's Incubator Grant announced
Jan 2017
New Research Projects commencing 2017 announced

Treating MS with cell and gene
therapy

Summary

The number and type of therapies we have for treating MS is continually growing. In the future, it may be possible to treat MS with cell-based therapies. In this method, specialised cells grown in the laboratory would be injected or transplanted into a person with MS, where they would release chemicals that can help fight the disease.

One of the major obstacles with cell-based therapies is controlling the growth of the cells once they are transplanted into a person. As these cells are similar to stem cells, they have the potential to grow into tumours and other unwanted growths. Dr Andras Nagy from the Australian Regenerative Medicine Institute, has developed a patented way to prevent this uncontrolled growth. In this incubator grant, Dr Natalie Payne from Monash University, will be adapting these cells to develop a potential therapy for MS.

Dr Payne is investigating a chemical called IL-1Beta that is released by cells in the immune system. This chemical has been associated with the initiation and maintenance of chronic or long lasting neuroinflammation, damage to the neurons, and demyelination, all of which result in the neurological symptoms of MS.

Dr Payne aims to create cells that will release a chemical that binds to IL-1Beta, thereby preventing it from initiating the pathway that leads to damages to the neuronal tissues. Dr Payne will then transplant these cells into a laboratory model of MS, and determine if they can prevent neuroinflammation and demyelination.

This clinically relevant project will determine if this approach can limit key steps in the pathway to tissue destruction, but also validate that cell-based therapies for MS are a feasible option.

 

Trish Foundation & MS Research Australia Working together to find a cure for MS
Copyright © Trish Multiple Sclerosis Research Foundation. All rights reserved.